Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406

Michinori Ogura; Kazuhito Yamamoto; Yasuo Morishima; Masashi Wakabayashi; Kensei Tobinai; Kiyoshi Ando; Naokuni Uike; Mitsutoshi Kurosawa; Hiroshi Gomyo; Masafumi Taniwaki; Kisato Nosaka; Norifumi Tsukamoto; Tatsu Shimoyama; Noriko Fukuhara; Yoshihiro Yakushijin; Kazunori Ohnishi; Kana Miyazaki; Yoshihiro Kameoka; Nobuyuki Takayama; Ichiro Hanamura; Hirofumi Kobayashi; Kensuke Usuki; Naoki Kobayashi; Kazuma Ohyashiki; Takahiko Utsumi; Kyoya Kumagai; Dai Maruyama; Ken Ohmachi; Yoshihiro Matsuno; Shigeo Nakamura; Tomomitsu Hotta; Kunihiro Tsukasaki; Hirokazu Nagai

doi:10.1111/cas.15849

Long-term follow-up after R-High CHOP/CHASER/LEED with Auto-PBSCT in untreated mantle cell lymphoma-Final analysis of JCOG0406

Cancer Sci. 2023 Aug;114(8):3461-3465. doi: 10.1111/cas.15849. Epub 2023 May 26.

Authors

Michinori Ogura^{1

2}, Kazuhito Yamamoto³, Yasuo Morishima³, Masashi Wakabayashi⁴, Kensei Tobinai⁵, Kiyoshi Ando⁶, Naokuni Uike⁷, Mitsutoshi Kurosawa⁸, Hiroshi Gomyo⁹, Masafumi Taniwaki¹⁰, Kisato Nosaka¹¹, Norifumi Tsukamoto¹², Tatsu Shimoyama¹³, Noriko Fukuhara¹⁴, Yoshihiro Yakushijin¹⁵, Kazunori Ohnishi¹⁶, Kana Miyazaki¹⁷, Yoshihiro Kameoka¹⁸, Nobuyuki Takayama¹⁹, Ichiro Hanamura²⁰, Hirofumi Kobayashi²¹, Kensuke Usuki²², Naoki Kobayashi²³, Kazuma Ohyashiki²⁴, Takahiko Utsumi²⁵, Kyoya Kumagai²⁶, Dai Maruyama⁵, Ken Ohmachi⁶, Yoshihiro Matsuno²⁷, Shigeo Nakamura²⁸, Tomomitsu Hotta²⁹, Kunihiro Tsukasaki³⁰, Hirokazu Nagai³¹

Affiliations

¹ Department of Hematology, Aichi Sannomaru Clinic, Nagoya, Japan.
² Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
³ Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
⁴ JCOG Data Center, National Cancer Center Hospital, Tokyo, Japan.
⁵ Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
⁶ Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan.
⁷ Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
⁸ Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan.
⁹ Department of Hematology, Hyogo Cancer Center, Akashi, Japan.
¹⁰ Department of Hematology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
¹¹ Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan.
¹² Department of Hematology, Gunma University Hospital, Maebashi, Japan.
¹³ Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Tokyo, Japan.
¹⁴ Department of Hematology, Tohoku University Hospital, Sendai, Japan.
¹⁵ First Department of Internal Medicine, Ehime University Graduate School of Medicine, Tohon-shi, Japan.
¹⁶ Department of Hematology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
¹⁷ Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
¹⁸ Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
¹⁹ Second Department of Internal Medicine, Kyorin University School of Medicine, Mitaka, Japan.
²⁰ Division of Hematology, Department of Internal Medicine, Aichi Medical University, Nagakute, Japan.
²¹ Department of Hematology, Saitama Cancer Center Hospital, Saitama, Japan.
²² Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
²³ Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
²⁴ Department of Hematology, Tokyo Medical University, Tokyo, Japan.
²⁵ Department of Hematology, Shiga General Hospital, Moriyama, Japan.
²⁶ Department of Hematology, Chiba Cancer Center, Chiba, Japan.
²⁷ Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
²⁸ Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya, Japan.
²⁹ National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
³⁰ Department of Hematology, National Cancer Center East, Kashiwa, Japan.
³¹ Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

Abstract

Progression-free survival after R-High CHOP/CHASER/LEED with auto-PBSCT in untreated mantle cell lymphoma in JCOG0406 study. A continuous pattern of relapse was observed.

Publication types

Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cyclophosphamide / therapeutic use
Doxorubicin / therapeutic use
Follow-Up Studies
Humans
Lymphoma, Mantle-Cell* / diagnostic imaging
Lymphoma, Mantle-Cell* / drug therapy
Neoplasm Recurrence, Local
Prednisone / therapeutic use
Rituximab / therapeutic use
Vincristine / therapeutic use

Substances

Rituximab
Vincristine
Cyclophosphamide
Doxorubicin
Prednisone

Abstract

Publication types

MeSH terms

Substances

Grants and funding